The overall goal of the proposed experiments is to determine the molecular mechanisms involved in the regulation of cardiac muscle contraction by troponin and to determine its role in familial hypertrophic cardiomyopathy (FHC).
SPECIFIC AIM 1. Cardiac TnT (CTnT) Isoforms and the Regulation of Contraction. CTnT isoforms are generated mainly by alternative splicing of two exons encoding the N-terminal variable region and are expressed in the human heart as four isoforms (HCTnT1 through HCTnT4). The expression of these isoforms at the protein level has previously been found to differ in the normal and failing adult and fetal human heart. Based on recent results from this laboratory we hypothesize that HCTnT N-terminal isoforms modulate Ca2+-sensitivity and the relaxation properties of cardiac muscle. In order to determine the fundamental role of HCTnT isoforms in the regulation of cardiac muscle contraction and to test this hypothesis, we will substitute the various CTnT isoforms into reconstituted skinned muscle and thin filament systems and study their individual properties.
SPECIFIC AIM 2. Functional Consequences of Tn FHC Mutations. Our working hypothesis is that mutations in Tn subunits lead to changes in the interactions between the CTn subunits and or changes in their interaction with other thin filament proteins, which in turn lead to changes in the Ca2+-affinity of CTnC and or changes in muscle mechanics eventually resulting in FHC. We propose to address the following issues: 1) to determine the in vitro properties of different Arg mutations in HCTnl (Arg 21, Arg 145 and Arg 204). Arg FHC mutations in HCTnT and HCTnl have been reported to be mutated to six different amino acids (Cys, Gly, Trp, Leu, Pro, and Gin); 2) to determine the in vitro properties of different Arg mutations in HCTnT (Arg 92, Arg 94, Arg 130 and Arg 278); 3) to characterize the first FHC mutant found in HCTnC; and 4) to determine the effect of different ratios of TnT, Tnl and TnC FHC mutants on the Ca 2+- sensitivity and level of actomyosin ATPase activity. ? All of the Specific Aims listed above focus on the effect of cardiac Tn, containing CTn subunits with FHC mutations, on the regulation of cardiac muscle contraction. Knowledge on these mutations will provide insights into the mechanisms by which these mutations cause cardiac disease as well as provide information about the importance of various regions in these CTn subunits. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL042325-15
Application #
6610614
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Buxton, Denis B
Project Start
1989-04-01
Project End
2007-03-31
Budget Start
2003-04-15
Budget End
2004-03-31
Support Year
15
Fiscal Year
2003
Total Cost
$366,334
Indirect Cost
Name
University of Miami School of Medicine
Department
Pharmacology
Type
Schools of Medicine
DUNS #
052780918
City
Miami
State
FL
Country
United States
Zip Code
33146
Liang, Jingsheng; Kazmierczak, Katarzyna; Rojas, Ana I et al. (2015) The R21C Mutation in Cardiac Troponin I Imposes Differences in Contractile Force Generation between the Left and Right Ventricles of Knock-In Mice. Biomed Res Int 2015:742536
Chang, Audrey N; Greenfield, Norma J; Singh, Abhishek et al. (2014) Structural and protein interaction effects of hypertrophic and dilated cardiomyopathic mutations in alpha-tropomyosin. Front Physiol 5:460
Wang, Yingcai; Pinto, Jose Renato; Solis, Raquel Sancho et al. (2012) Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy. J Biol Chem 287:2156-67
Pinto, Jose Renato; Gomes, Aldrin V; Jones, Michelle A et al. (2012) The functional properties of human slow skeletal troponin T isoforms in cardiac muscle regulation. J Biol Chem 287:37362-70
Parvatiyar, Michelle S; Landstrom, Andrew P; Figueiredo-Freitas, Cicero et al. (2012) A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation. J Biol Chem 287:31845-55
Pinto, Jose Renato; Reynaldo, Daniel P; Parvatiyar, Michelle S et al. (2011) Strong cross-bridges potentiate the Ca(2+) affinity changes produced by hypertrophic cardiomyopathy cardiac troponin C mutants in myofilaments: a fast kinetic approach. J Biol Chem 286:1005-13
Pinto, Jose Renato; Siegfried, Jill D; Parvatiyar, Michelle S et al. (2011) Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy. J Biol Chem 286:34404-12
Midde, K; Dumka, V; Pinto, J R et al. (2011) Myosin cross-bridges do not form precise rigor bonds in hypertrophic heart muscle carrying troponin T mutations. J Mol Cell Cardiol 51:409-18
Pinto, Jose Renato; Yang, Shi Wei; Hitz, Marc-Phillip et al. (2011) Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach. J Biol Chem 286:20901-12
Dweck, David; Reynaldo, Daniel P; Pinto, Jose R et al. (2010) A dilated cardiomyopathy troponin C mutation lowers contractile force by reducing strong myosin-actin binding. J Biol Chem 285:17371-9

Showing the most recent 10 out of 53 publications